top of page

Our News 

Recent News Stories, Press Releases, and Company Announcements


Hememics Closes $2 Million in Seed 2 Financing from TEDCO and Qualified Investors

Hememics Biotechnologies, Inc Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth.



COVID-19 Rapid Test Kits Global Market Report 2021

Hememics Biotechnologies Inc. partnered with Biomedical Research and Development Authority (BARDA) to develop a rapid antibody and antigen diagnostic tool.


Graphene Biosensor Evolution: The Practical Applications of Graphene

Graphene's unique properties provide some very practical applications in biosensors. 

Screenshot 2022-08-12 145837.png



Hememics Biotechnologies Inc. Receives $400k Investment From Dai Viet Inc.

Dai Viet invests $400k into Hememics. 


Not All COVID-19 Tests Are Created Equal  - New Biosensors to Improve Speed and Connectivity

As the COVID-19 pandemic rages on, Hememics Biotechnologies's Biosensors are redefining rapid tests. 

Screen Shot 2022-08-04 at 2.50.02 PM.png


Dai Viet.jpeg

Dai Viet Signs for Investment Cooperation with Hememics Biotechnologies Inc. USA

Dai Viet group invests in Hememics.


NOVA Investors Band Together and Invest in Hememics

Local businesses and entities in Northern Virginia (NOVA) have banded together to invest in Hememics. 



Screen Shot 2022-08-05 at 10.03.15 AM.png

Biosensors May Hold the Key to Mass Coronavirus Testing

Dry proteins are Hememics "Special Sauce" in antigen detection.


New Coronavirus Test Could Diagnose the Virus in 60 Seconds or Less

The potential for the Hememics biosensor to detect COVID in under a minute has the potential to address a critical issue in identifying those with active infections vs those with antibodies.

Screen Shot 2022-12-20 at 10.42.36 AM.png


Hememics Biotechnologies Inc. Received a $2.5 Million Investment from AMVI Partners

Hememics Biotechnologies received support from investment firm AMVI and plans to utilize the funds in the development and commercialization of Hememics technologies.


Inova Personalized Health Accelerator Accepts Hememics Biotechnologies, Inc. Into Portfolio

Hememics enters Inova investment portfolio.

Screen Shot 2022-08-04 at 3.29.38 PM.png
bottom of page